Peptoniphilus lacrimalis Details: NCBI 33031, gram-negative or unknown [species]

| "Schleiferella lacrimalis" Rajendram et al. 2001| ATCC 51171| CCUG 31350| CIP 103724| DSM 7455| GIFU 7667| GIFU:7667| JCM 8139| NCTC 13149| Peptoniphilus lacrimalis| Peptoniphilus lacrimalis (Li et al. 1992) Ezaki et al. 2001| Peptostreptococcus lacrimalis| Peptostreptococcus lacrimalis Li et al. 1992| Schleiferella lacrimalis

  1. Infections: Peptoniphilus lacrimalis has been reported as an opportunistic pathogen in humans, particularly in individuals with compromised immune systems or underlying medical conditions. It can cause infections such as skin and soft tissue infections, abscesses, wound infections, and infections of the genitourinary tract. Peptoniphilus lacrimalis is often found as part of polymicrobial infections, where multiple bacterial species are involved.

  2. Bacteremia: In severe cases, infections caused by Peptoniphilus lacrimalis can lead to bacteremia, a condition characterized by the presence of bacteria in the bloodstream. Bacteremia can result from the spread of infection from a localized site to the bloodstream or from invasive medical procedures. If not promptly treated with appropriate antibiotics, bacteremia can lead to sepsis, a life-threatening systemic inflammatory response.

  3. Endocarditis: Peptoniphilus lacrimalis has been implicated as a causative agent of infective endocarditis, an infection of the inner lining of the heart chambers and valves. Endocarditis typically occurs when bacteria enter the bloodstream and adhere to damaged areas of the heart, forming vegetations. These vegetations can impair heart function and lead to complications such as embolism (the spread of infected material to other parts of the body) and heart valve damage.

  4. Antimicrobial resistance: Some strains of Peptoniphilus lacrimalis may exhibit resistance to certain antibiotics, which can complicate treatment of infections caused by these bacteria. Resistance mechanisms may involve the production of enzymes that inactivate antibiotics, alterations in bacterial cell structure to prevent antibiotic entry, or efflux pumps that expel antibiotics from the bacterial cell.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Peptoniphilus lacrimalis

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.09 10 20 1 29 15 15 7.1 10 20 25 %ile 50 %ile
biomesight 16.55 0 10 10 220 0 1488 226.6 40 643.8 0 200 0 %ile 92 %ile
thorne 10.34 1 4 0 5 2 1 1.7 1 4 20 %ile 60 %ile
thryve 25.45 0 15 3 221 0 3750 421.3 38 1698.1 5 207 0 %ile 92 %ile
ubiome 20.79 0 25 18 35666 0 10468 1514.9 147 4568.1 0 1177 0 %ile 100 %ile

External Reference Ranges for Peptoniphilus lacrimalis

Peptoniphilus lacrimalis (NCBI 33031) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Peptoniphilus lacrimalis
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 17.184 %   0.023 %  0.061 % 509.0 2962
CosmosId 6.25 %   0.002 %  0.001 % 2.0 32
Thorne 4.95 %   0 %  0 % 5.0 101
Thryve 23.614 %   0.055 %  0.201 % 328.0 1389
uBiome 20.707 %   0.151 %  0.457 % 164.0 792

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Antibiotics, Antivirals etc metronidazole (antibiotic)s[CFS] 1 Studies recorded. The consensus is Increases📓, Click for details.
Diet Style ketogenic diet 1 Studies recorded. The consensus is Increases📓, Click for details.
Diet Style mediterranean diet 1 Studies recorded. The consensus is Increases📓, Click for details.
flavonoids, polyphenols etc resveratrol (grape seed/polyphenols/red wine) 1 Studies recorded. The consensus is Decreases📓, Click for details.
Food (excluding seasonings) ku ding cha tea 1 Studies recorded. The consensus is Decreases📓, Click for details.
Food (excluding seasonings) navy bean 1 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) pea (fiber, protein) 1 Studies recorded. The consensus is Increases📓, Click for details.
Not Classified Mold and Home Dampness 1 Studies recorded. The consensus is Increases👶, Click for details.
Prebiotics and similar mastic gum (prebiotic) 1 Studies recorded. The consensus is Decreases📓, Click for details.
Prescription - Other polymannuronic acid 1 Studies recorded. The consensus is Increases📓, Click for details.
Probiotics lactobacillus gasseri (probiotics) 1 Studies recorded. The consensus is Increases📓, Click for details.
Probiotics lactobacillus reuteri (probiotics) 1 Studies recorded. The consensus is Increases📓, Click for details.
Sugar and similar sugar 1 Studies recorded. The consensus is Decreases📓, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.